Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Rheumatoid Arthritis (80mg Monthly vs 40mg Every Other Week)
NCT00647270Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of Trudexa in rheumatoid arthritis (RA) (3 arms), sponsored by Abbott Laboratories. Primary endpoint: American College of Rheumatology 20 Response Criteria at 12 weeks. Started Dec 2007; status: completed.
02
Drugs
Trudexa
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00647270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647270.